Hain Debra, Tomlin Holly, Gibson Cristian
Professor, MSN Coordinator: AGNP Concentration, Florida Atlantic University, Christine E Lynn College of Nursing, Boca Raton, FL.
Nurse Practitioner, Cleveland Clinic Florida, Department of Nephrology, Weston, FL.
Nephrol Nurs J. 2019 May-Jun;46(3):315-290.
The number, volume, and timing of oral medications prescribed to treat secondary hyperparathyroidism can add to the burden of disease management for both the patient and the nurse. Administering intravenous (IV) medication when possible has the potential of reducing the burden of medication management. Data on the use of IV calcimimetic etelcalcetide has shown improvement in blood calcium, phosphorus, and parathyroid hormone levels. IV administration of etelcalcetide at the end of each hemodialysis session may reduce the pill burden for patients and has the potential to help improve disease management within an environment that supports person-centered care.
用于治疗继发性甲状旁腺功能亢进的口服药物的数量、剂量和服用时间，会增加患者和护士疾病管理的负担。尽可能给予静脉注射药物有可能减轻药物管理的负担。有关静脉注射拟钙剂依特卡肽使用的数据表明，血钙、血磷和甲状旁腺激素水平有所改善。在每次血液透析疗程结束时静脉注射依特卡肽，可能会减轻患者的服药负担，并有可能在以患者为中心的护理环境中帮助改善疾病管理。
